Literature DB >> 1321839

Detection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues.

L M Weiss1, X F Liu, K L Chang, M E Billingham.   

Abstract

Enteroviruses have been considered to be a possible cause of idiopathic dilated cardiomyopathy. We used a polymerase chain reaction methodology for the identification of enteroviral RNA in an attempt to provide evidence of a role for enteroviruses in the pathogenesis of idiopathic dilated cardiomyopathy. The methodology was shown to identify a wide variety of enteroviruses with a sensitivity up to 0.1-1 plaque-forming units/gram of tissue. 5 of 11 cases (45%) of idiopathic dilated cardiomyopathy, as well as 9 of 24 cases (38%) of a wide variety of other cardiac conditions (including normal heart), were positive for enteroviral nucleic acid sequences; all eight control cases of breast carcinoma tested were negative. These results suggest that both the normal and abnormal heart may represent a site of latent or low-grade persistent enteroviral infection, and that the mere presence of enteroviral nucleic acid sequences is not specifically associated with idiopathic dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321839      PMCID: PMC443075          DOI: 10.1172/JCI115830

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  Antibodies to Coxsackie B viruses in congestive cardiomyopathy.

Authors:  G Cambridge; C G MacArthur; A P Waterson; J F Goodwin; C M Oakley
Journal:  Br Heart J       Date:  1979-06

2.  Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction.

Authors:  J Ben-Ezra; D A Johnson; J Rossi; N Cook; A Wu
Journal:  J Histochem Cytochem       Date:  1991-03       Impact factor: 2.479

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Myocarditis. A histopathologic definition and classification.

Authors:  H T Aretz; M E Billingham; W D Edwards; S M Factor; J T Fallon; J J Fenoglio; E G Olsen; F J Schoen
Journal:  Am J Cardiovasc Pathol       Date:  1987-01

5.  Nonisotopic oligomeric probes for the human enteroviruses.

Authors:  H A Rotbart; P S Eastman; J L Ruth; K K Hirata; M J Levin
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

6.  Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemia.

Authors:  S Kohler; N Galili; J L Sklar; T A Donlon; K G Blume; M L Cleary
Journal:  Leukemia       Date:  1990-08       Impact factor: 11.528

7.  Pathologic anatomy of the cardiomyopathies. Idiopathic dilated and hypertrophic types, infiltrative types, and endomyocardial disease with and without eosinophilia.

Authors:  W C Roberts; V J Ferrans
Journal:  Hum Pathol       Date:  1975-05       Impact factor: 3.466

8.  Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction.

Authors:  O Jin; M J Sole; J W Butany; W K Chia; P R McLaughlin; P Liu; C C Liew
Journal:  Circulation       Date:  1990-07       Impact factor: 29.690

9.  Detection of Coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction.

Authors:  L M Weiss; L A Movahed; M E Billingham; M L Cleary
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

10.  Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains.

Authors:  C J Gauntt; P T Gomez; P S Duffey; J A Grant; D W Trent; S M Witherspoon; R E Paque
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

View more
  10 in total

1.  Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones initial results.

Authors:  M Mirić; J Vasiljević; M Bojić; Z Popović; N Keserović; M Pesić
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

Review 2.  [Enteroviral myocarditis and dilated cardiomyopathy].

Authors:  R Kandolf
Journal:  Med Klin (Munich)       Date:  1998-04-15

3.  Reverse transcription PCR to detect enteroviruses in surface water.

Authors:  M Gilgen; B Wegmüller; P Burkhalter; H P Bühler; U Müller; J Lüthy; U Candrian
Journal:  Appl Environ Microbiol       Date:  1995-04       Impact factor: 4.792

4.  Absence of linkage between idiopathic dilated cardiomyopathy and candidate genes involved in the immune function in a large Italian pedigree.

Authors:  M Krajinovic; L Mestroni; G M Severini; B Pinamonti; F Camerini; A Falaschi; M Giacca
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

Review 5.  Familial dilated cardiomyopathy.

Authors:  L Mestroni; M Krajinovic; G M Severini; B Pinamonti; A Di Lenarda; M Giacca; A Falaschi; F Camerini
Journal:  Br Heart J       Date:  1994-12

Review 6.  Link between enteroviruses and dilated cardiomyopathy: serological and molecular data.

Authors:  P J Keeling; S Tracy
Journal:  Br Heart J       Date:  1994-12

7.  The role of viral infections in the development of dilated cardiomyopathy.

Authors:  Eniko Tátrai; István Hartyánszky; András Lászik; György Acsády; Péter Sótonyi; Márta Hubay
Journal:  Pathol Oncol Res       Date:  2010-09-18       Impact factor: 3.201

8.  Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy.

Authors:  Ulrich Lotze; Renate Egerer; Christiane Tresselt; Brigitte Glück; Gudrun Dannberg; Axel Stelzner; Hans R Figulla
Journal:  Med Microbiol Immunol       Date:  2003-12-20       Impact factor: 3.402

9.  Use of the polymerase chain reaction with a murine model of picornavirus-induced myocarditis.

Authors:  I Leparc; F Fuchs; H Kopecka; M Aymard
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

Review 10.  Viral myocarditis: diagnosis, aetiology and management.

Authors:  Uwe Kühl; Heinz-Peter Schultheiss
Journal:  Drugs       Date:  2009-07-09       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.